Inflammation

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib
Jonathan Kay, Masayoshi Harigai, Josh Rancourt, Christina Dickson, Thomas Melby, Maher Issa, Inmaculada de la Torre, Yoshitaka Isaka, Anabela Cardoso, Chadi Saifan, Edward C Keystone, Ronald F van Vollenhoven, Jon T Giles, Tom WJ Huizinga, Joel M Kremer

RMD Open Oct 2020, 6 (3) e001370; DOI: 10.1136/rmdopen-2020-001370
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study
James Galloway, Kevin Barrett, Peter Irving, Kaivan Khavandi, Monica Nijher, Ruth Nicholson, Simon de Lusignan, Maya H Buch

RMD Open Sep 2020, 6 (3) e001392; DOI: 10.1136/rmdopen-2020-001392
Preclinical to clinical translation of cenerimod, a novel S1P₁ receptor modulator, in systemic lupus erythematosus
Daniel S Strasser, Sylvie Froidevaux, Virginie Sippel, Estelle Gerossier, Ursula Grieder, Gabin M Pierlot, Andrea Kieninger-Graefitsch, Enrico Vezzali, Anna K Stalder, Bérengère Renault, Jesper Ryge, Aaron Hart, Ulrich Mentzel, Peter M A Groenen, Marcel P Keller, Marten Trendelenburg, Marianne M Martinic, Mark J Murphy

RMD Open Sep 2020, 6 (2) e001261; DOI: 10.1136/rmdopen-2020-001261
Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells
Mittal Shah, Asher Maroof, Panos Gikas, Gayatri Mittal, Richard Keen, Dominique Baeten, Stevan Shaw, Scott J Roberts

RMD Open Jul 2020, 6 (2) e001306; DOI: 10.1136/rmdopen-2020-001306
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment
Jennifer C Davies, Angela Midgley, Emil Carlsson, Sean Donohue, Ian N Bruce, Michael W Beresford, Christian M Hedrich

RMD Open Jul 2020, 6 (2) e001257; DOI: 10.1136/rmdopen-2020-001257
Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
Mark Kacar, John Fitton, Andrew K Gough, Maya H Buch, Dennis G McGonagle, Sinisa Savic

RMD Open Jul 2020, 6 (2) e001246; DOI: 10.1136/rmdopen-2020-001246
Radiographic progression in clinical trials in rheumatoid arthritis: a systemic literature review of trials performed by industry
Yune-Jung Park, Ana Maria Gherghe, Desirée van der Heijde

RMD Open Jul 2020, 6 (2) e001277; DOI: 10.1136/rmdopen-2020-001277
Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis
Marian van Beers-Tas, Markus MJ Nielen, Jos W R Twisk, Joke Korevaar, D van Schaardenburg

RMD Open Jul 2020, 6 (2) e001163; DOI: 10.1136/rmdopen-2019-001163
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
Maarten R Hillen, Katia Urso, Emma Koppe, Ana Pinheiro Lopes, Sofie L M Blokland, Aridaman Pandit, Tom Slocombe, André van Maurik, Joel A G van Roon, Timothy R D J Radstake

RMD Open Jun 2020, 6 (2) e001184; DOI: 10.1136/rmdopen-2020-001184
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio

RMD Open May 2020, 6 (1) e001295; DOI: 10.1136/rmdopen-2020-001295

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages